Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-19

Clinical Trial Update: Colchicine in Patients With Heart Failure With Preserved Ejection Fraction and Inflammation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating colchicine for patients with heart failure with preserved ejection fraction and inflammation; the trial is not yet recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COLCHICINE (Colchicine)

Snippet

Sponsor: Dongying Zhang | Conditions: Heart Failure, Heart Failure With Preserved Ejection Fraction (HFPEF) | Phase 4 | Status: NOT_YET_RECRUITING